NAR CANCER : Impact Factor & More
eISSN: 2632-8674pISSN: 2632-8674
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on NAR CANCER
NAR CANCER Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | OXFORD UNIV PRESS |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | USD 2225 |
| Publication Time | 13 |
| Editorial Review Process | Peer review |
| General Details | |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in NAR CANCER ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in NAR CANCER
Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancer
- 23 Jun 2026
- NAR Cancer
Loss of CHTF18\u2013RFC2/5 leads to replicative gaps and sensitivity to PARP inhibitors
- 3 Jun 2026
- NAR Cancer
Disruption of the structural maintenance of chromosomes 5/6 complex enables tumor mutagenesis
- 21 May 2026
- NAR Cancer
Sensitive detection of somatic mutations in GC-rich cancer gene promoters
- 4 May 2026
- NAR Cancer
MYC and AP-1 oncogenes cooperatively bind enhancers to rewire transcription.
- 8 Apr 2026
- NAR cancer
Uncovering novel germline variants associated with testicular germ cell tumors by exome sequencing.
- 8 Apr 2026
- NAR cancer
Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancer
- 23 Jun 2026
- NAR Cancer
Loss of CHTF18\u2013RFC2/5 leads to replicative gaps and sensitivity to PARP inhibitors
- 3 Jun 2026
- NAR Cancer
Disruption of the structural maintenance of chromosomes 5/6 complex enables tumor mutagenesis
- 21 May 2026
- NAR Cancer
Sensitive detection of somatic mutations in GC-rich cancer gene promoters
- 4 May 2026
- NAR Cancer
MYC and AP-1 oncogenes cooperatively bind enhancers to rewire transcription.
- 8 Apr 2026
- NAR cancer
Uncovering novel germline variants associated with testicular germ cell tumors by exome sequencing.
- 8 Apr 2026
- NAR cancer
FAQs on NAR CANCER
What is the publishing frequency of NAR CANCER? 
How many articles did NAR CANCER publish last year?
What is the eISSN & pISSN for NAR CANCER?
Who is the publisher of NAR CANCER?
